Dental Unit Waterline Biofilm: Why It Forms, What UK Guidance Expects and What the 2026 Evidence Shows

Why waterlines grow biofilm so readily

A dental chair unit feeds handpieces, three-in-one syringes and ultrasonic scalers through metres of small-bore tubing, typically a few millimetres in diameter. The ratio of wetted surface to water volume is therefore very high, the water is at or near room temperature for most of the day, flow is intermittent and laminar, and the tubing sits stagnant overnight and over weekends. Polymer surfaces adsorb organic material, and the bacteria in incoming mains water or a bottled reservoir attach, produce extracellular polymeric substance and colonise the lumen. Once established, a waterline biofilm continuously seeds the water passing over it, which is why an unmanaged unit can deliver water with heterotrophic counts far above the mains it was filled from.

The organisms are mostly environmental and of low virulence, but the population can include Pseudomonas species, non-tuberculous mycobacteria and Legionella, and the exposure route (aerosols close to the patient's and clinician's airway, and water delivered into surgical sites) is a reason regulators treat waterline quality as a patient-safety matter rather than a cosmetic one.

What UK and international guidance expects

In England, Health Technical Memorandum 01-05 (Decontamination in primary care dental practices) is the reference document for waterline management. It expects practices to have a written waterline management protocol, to use an appropriate treatment (continuous or periodic) in line with the manufacturer's instructions for the chair and the treatment product, to flush lines at the start of the day and between patients, and to drain and dry independent reservoirs at the end of the day. It does not generally call for routine microbiological monitoring of waterline output; testing is advised where taste, odour or other evidence suggests a problem, or where a practice's own risk assessment requires it. Practices should work from the current published edition and their chair manufacturer's guidance rather than from a summary such as this one. HTM 01-05 also sits alongside the general legionella framework: the dental chair is a water system, so it belongs within the practice's legionella risk assessment under HSE's Approved Code of Practice L8 and HSG274.

Internationally, the US Centers for Disease Control and Prevention recommend that water used for non-surgical dental procedures meet the regulatory standard for drinking water (no more than 500 colony-forming units of heterotrophic bacteria per millilitre), and that sterile water or saline be used for surgical procedures. Any product used to treat waterline water in Great Britain is a biocidal product and must be compliant for that use under GB BPR; the correct product type depends on the claim and the product's authorisation, so confirm it with the supplier rather than assuming it.

Control principles that follow from the biology

Because biofilm re-seeds the water, waterline management has two parts that are easy to conflate. The first is treating the water, which controls the planktonic count that reaches the patient. The second is controlling the attached growth, which determines how quickly the count climbs again after treatment stops. A shock or periodic treatment addresses the second part briefly; a continuous treatment holds the first part between shocks and slows recolonisation. Flushing removes stagnant water but does not remove established biofilm. Draining and drying a reservoir reduces overnight growth in the bottle but not in the tubing. A monitoring result reflects the water at the time of sampling and says nothing about attached growth unless the count is tracked over time.

The narrow tubing also means that any oxidising disinfectant is consumed quickly. A concentration measured at the bottle is not the concentration at the handpiece after a stagnant period. That single fact explains much of the difference between products and protocols that look similar on paper.

The 2026 PLOS ONE chlorine dioxide study, briefly

A 5 March 2026 paper in PLOS ONE (Winkler and colleagues; doi 10.1371/journal.pone.0342347) compared chlorine dioxide flushing protocols in a dental chair unit. A single shock at about 22.7 mg/L produced a transient reduction of roughly 2.5 log that was lost within days as the biofilm re-seeded the water; continuous dosing at about 1.2 mg/L sustained the reduction, and raising the continuous concentration to about 2.4 mg/L gave no additional benefit. The authors also documented rapid depletion of chlorine dioxide along the polymer tubing. Our companion guide on disinfectant depletion and regrowth covers the study in detail.

The study used a commercial German chlorine dioxide concentrate (Clorious2, a.p.f Aqua System) diluted by the researchers, with three authors affiliated to that company and public grant funding declared. It did not use a ChloroKlean product or any commercially supplied UK dental waterline treatment, and it does not establish a dose, contact time, frequency or efficacy claim for ChloroKlean or for any other named product. Its findings describe one dental chair unit under controlled conditions. What it demonstrates is the mechanism described above: in a small-bore polymer system, a treatment that is present continuously controls the water better than one that is present briefly, and concentration beyond what the system can hold is not rewarded.

What the evidence does and does not establish

It establishes that dental waterline biofilm forms quickly, re-seeds treated water within days, and consumes oxidising disinfectants faster than larger water systems do, and that in one 2026 study continuous low-level chlorine dioxide outperformed periodic shocks on those terms.

It does not establish which product a practice should use, what concentration or protocol is appropriate for a particular chair, or that any chlorine dioxide product is authorised or suitable for waterline use in Great Britain. Those decisions rest on the chair manufacturer's instructions, the product's GB BPR status and label, the practice's HTM 01-05 protocol and legionella risk assessment, and monitoring results. ChloroKlean does not currently publish a dental waterline dosing protocol, and this guide should not be read as one.

Evidence and uncertainty

Published biofilm studies are valuable for understanding mechanisms, but their conditions may not match a particular installation. Species, surfaces, deposits and operating conditions should be recorded when interpreting evidence.

For safety-critical systems, decisions should be documented through the relevant risk assessment and management plan.

Choosing the next question

A useful next step is to identify what is known, what is inferred and what needs verification. This avoids treating a general reference as a site diagnosis.

Where a product is considered, confirm the intended use, authorisation and label directions independently of this educational guide.

Use this sequence to frame investigation and control; it is not a dosing protocol.

Expert Insights

About the Reviewer

Frequently Asked Questions

Common questions about this topic, answered by our technical team.

Related Resources

Continue exploring our knowledge base and product information.